Lewy body pathology is associated with mitochondrial DNA damage in Parkinson's disease
Authors:
- Sarina K. MüllerSMSarina K. Müller
- Andreas BenderABAndreas Bender
- Christoph LaubCLChristoph Laub
- Tobias HögenTHTobias Högen
- Falk SchlaudraffFSFalk Schlaudraff
- Birgit LissBLBirgit Liss
- Thomas KlopstockTKThomas Klopstock
- Matthias ElstnerMEMatthias Elstner
- 1 September 2013
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 34 (9) , 2231-2233
Abstract
No abstract availableKeywords
Funding Information
- Else-Kröner-Fresenius-Stiftung (P65/06//EKMS 06/13)
- Deutsche Forschungsgemeinschaft (BE 4185/1-1)
- Nationales Genomforschungsnetz
- German Federal Ministry of Education and Research (01EO0901)
This publication has 14 references indexed in Scilit:
- Transcriptome analysis in mitochondrial disordersBrain Research Bulletin, 2012
- A mitochondrial etiology of Alzheimer and Parkinson diseaseBiochimica et Biophysica Acta (BBA) - General Subjects, 2012
- Somatic mitochondrial DNA mutations in early parkinson and incidental lewy body diseaseAnnals of Neurology, 2012
- The role of α-synuclein in neurodegeneration — An updateTranslational Neuroscience, 2012
- Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletionsMolecular Brain, 2011
- What causes mitochondrial DNA deletions in human cells?Nature Genetics, 2008
- High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson diseaseNature Genetics, 2006
- Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease: An immunohistochemical and morphometric studyMovement Disorders, 1997
- Electron transport chain defects in Alzheimer's disease brainNeurology, 1994
- Brain Cytochrome Oxidase in Alzheimer's DiseaseJournal of Neurochemistry, 1992